AU2020901243A0 - Modified macrophages, compositions and uses thereof - Google Patents

Modified macrophages, compositions and uses thereof

Info

Publication number
AU2020901243A0
AU2020901243A0 AU2020901243A AU2020901243A AU2020901243A0 AU 2020901243 A0 AU2020901243 A0 AU 2020901243A0 AU 2020901243 A AU2020901243 A AU 2020901243A AU 2020901243 A AU2020901243 A AU 2020901243A AU 2020901243 A0 AU2020901243 A0 AU 2020901243A0
Authority
AU
Australia
Prior art keywords
compositions
modified macrophages
macrophages
modified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020901243A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duogenic StemCells Corporation
Original Assignee
Duogenic StemCells Corporation
Filing date
Publication date
Application filed by Duogenic StemCells Corporation filed Critical Duogenic StemCells Corporation
Publication of AU2020901243A0 publication Critical patent/AU2020901243A0/en
Priority to MX2022013093A priority Critical patent/MX2022013093A/en
Priority to EP21791825.9A priority patent/EP4139441A4/en
Priority to CA3173916A priority patent/CA3173916A1/en
Priority to TW110113873A priority patent/TW202204610A/en
Priority to CN202180029356.6A priority patent/CN115667502A/en
Priority to US17/919,564 priority patent/US20230142987A1/en
Priority to AU2021261147A priority patent/AU2021261147A1/en
Priority to KR1020227036229A priority patent/KR20220156882A/en
Priority to JP2022551557A priority patent/JP2023521545A/en
Priority to BR112022021104A priority patent/BR112022021104A2/en
Priority to PCT/JP2021/015925 priority patent/WO2021215410A1/en
Priority to IL297366A priority patent/IL297366A/en
Pending legal-status Critical Current

Links

AU2020901243A 2020-04-20 2020-04-20 Modified macrophages, compositions and uses thereof Pending AU2020901243A0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
IL297366A IL297366A (en) 2020-04-20 2021-04-19 Modified macrophages, compositions and uses thereof
CN202180029356.6A CN115667502A (en) 2020-04-20 2021-04-19 Modified macrophages, compositions thereof and uses thereof
EP21791825.9A EP4139441A4 (en) 2020-04-20 2021-04-19 Modified macrophages, compositions and uses thereof
CA3173916A CA3173916A1 (en) 2020-04-20 2021-04-19 Modified macrophages, compositions and uses thereof
TW110113873A TW202204610A (en) 2020-04-20 2021-04-19 Modified macrophages, compositions and uses thereof
MX2022013093A MX2022013093A (en) 2020-04-20 2021-04-19 Modified macrophages, compositions and uses thereof.
US17/919,564 US20230142987A1 (en) 2020-04-20 2021-04-19 Modified macrophages, compositions and uses thereof
AU2021261147A AU2021261147A1 (en) 2020-04-20 2021-04-19 Modified macrophages, compositions and uses thereof
KR1020227036229A KR20220156882A (en) 2020-04-20 2021-04-19 Modified Macrophages, Compositions and Uses Thereof
JP2022551557A JP2023521545A (en) 2020-04-20 2021-04-19 Modified macrophages, compositions and uses thereof
BR112022021104A BR112022021104A2 (en) 2020-04-20 2021-04-19 MODIFIED MACROPHAGES, THEIR COMPOSITIONS AND THEIR USES
PCT/JP2021/015925 WO2021215410A1 (en) 2020-04-20 2021-04-19 Modified macrophages, compositions and uses thereof

Publications (1)

Publication Number Publication Date
AU2020901243A0 true AU2020901243A0 (en) 2020-05-07

Family

ID=

Similar Documents

Publication Publication Date Title
EP3990618A4 (en) Hdac6-activated macrophages, compositions, and uses thereof
EP3968963A4 (en) Imatinib formulations, manufacture, and uses thereof
AU2022344251A1 (en) Serpina-modulating compositions and methods
AU2022342169A1 (en) Hbb-modulating compositions and methods
AU2020901243A0 (en) Modified macrophages, compositions and uses thereof
EP4139441A4 (en) Modified macrophages, compositions and uses thereof
AU2022408218A1 (en) Tetrahydropyridazines, compositions comprising them and uses thereof
AU2021902682A0 (en) Compositions and uses thereof
AU2021902267A0 (en) Compositions and uses thereof
AU2021901822A0 (en) Compositions and uses thereof
AU2020904491A0 (en) Compositions and uses thereof
AU2021901646A0 (en) Compounds, compositions and uses thereof
AU2020903051A0 (en) Compounds, compositions and uses thereof
GB2609091B (en) Compositions, and methods and uses relating thereto
AU2022245340A1 (en) 2-amino-4-carboxamide-benzazepine immunoconjugates, and uses thereof
AU2021902138A0 (en) Composition and uses thereof
EP4175641A4 (en) Anti-inflammatory compositions, methods and uses thereof
AU2020903150A0 (en) Composition and uses thereof
EP4132988A4 (en) Xylitol-doped citrate compositions and uses thereof
GB202405929D0 (en) Compositions, uses and methods
GB202401977D0 (en) Compositions, methods and uses
GB202317451D0 (en) Compositions, methods and uses
GB202317463D0 (en) Compositions, methods and uses
GB202311075D0 (en) Compositions, methods and uses
GB202305630D0 (en) Compositions, methods and uses